AboutContactTerms & Privacy
© 2024 Coverager
All Rights Reserved

Upstream Bio

Antibody therapy for the treatment of severe asthma.

Headquarters
Waltham, Massachusetts, United States
Founded
2021
Operating Status
Active
Ownership Type
Business Model
Links
Number of funding rounds 4
Number of investors 14
Total funding amount $408M
Date Amount Stage Investors

Clients Only Feature

Client? Sign in to access this feature.
Not a client? Learn more about Coverager Research.